📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Eurand

1.1 - Company Overview

Eurand Logo

Eurand

Headquarter: The Netherlands
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty pharmaceutical and biopharmaceutical products, developing, manufacturing and commercializing a portfolio for cystic fibrosis and gastrointestinal patients in the United States.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Eurand

Pfizer Logo

Pfizer

HQ: United States Website
  • Description: Provider of biopharmaceutical medicines and health care services, delivering affordable access to safe, effective treatments, including vaccines for infectious diseases (COVID-19, pneumonia, meningitis), oncology therapies, cardiovascular medicines for hypertension and cholesterol, anti-infectives (antibiotics, antivirals), treatments for inflammation and immunology, and therapies for rare genetic disorders addressing unmet medical needs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pfizer company profile →
Solve Therapeutics Logo

Solve Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies developing antibody-drug conjugates and bispecific therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Solve Therapeutics company profile →
CohBar Logo

CohBar

HQ: United States Website
  • Description: Provider of mitochondria-based therapeutics as a clinical-stage biotechnology company developing CB4211 for NASH and obesity, showing reduced liver damage biomarkers and glucose levels; CB5138 analogs in preclinical development for IPF and other fibrotic diseases, reducing lung fibrosis and inflammation; and a Mitochondrial Genome Mining platform to discover therapeutic peptides.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CohBar company profile →
Biosplice Logo

Biosplice

HQ: United States Website
  • Description: Provider of therapeutic solutions and clinical trials for tissue-level regeneration, developing therapies that modulate alternative splicing via CLK/DYRK kinase inhibition to treat diseases like osteoarthritis and cancer. Offerings include Lorecivivint, an injectable small molecule for knee osteoarthritis to reduce pain, improve function, and protect cartilage, with trials evaluating safety, efficacy, and dosing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biosplice company profile →
Cumberland Pharmaceuticals Logo

Cumberland Pharmaceuticals

HQ: United States Website
  • Description: Provider of specialty pharmaceutical offerings focused on acquiring, developing, and commercializing branded prescription products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cumberland Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Eurand

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Eurand

2.2 - Growth funds investing in similar companies to Eurand

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Eurand

4.2 - Public trading comparable groups for Eurand

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Eurand

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Eurand

What does Eurand do?

Eurand is a provider of specialty pharmaceutical and biopharmaceutical products, developing, manufacturing and commercializing a portfolio for cystic fibrosis and gastrointestinal patients in the United States.

Who are Eurand's competitors?

Eurand's competitors and similar companies include Pfizer, Solve Therapeutics, CohBar, Biosplice, and Cumberland Pharmaceuticals.

Where is Eurand headquartered?

Eurand is headquartered in The Netherlands.

How many employees does Eurand have?

Eurand has 1,000 employees 🔒.

When was Eurand founded?

Eurand was founded in 2010 🔒.

What sector and industry vertical is Eurand in?

Eurand is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Eurand

Who are the top strategic acquirers in Eurand's sector and industry

Top strategic M&A buyers and acquirers in Eurand's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Eurand?

Top strategic M&A buyers groups and sectors for Eurand include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Eurand's sector and industry vertical

Which are the top PE firms investing in Eurand's sector and industry vertical?

Top PE firms investing in Eurand's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Eurand's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Eurand's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Eurand's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Eurand include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Eurand's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Eurand?

The key public trading comparables and valuation benchmarks for Eurand include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Eurand for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Eurand with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Eurand's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Eurand with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Eurand's' sector and industry vertical?

Access recent funding rounds and capital raises in Eurand's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Eurand